*ST赛隆：全资子公司获得法莫替丁注射液药品注册证书

Group 1 - The core point of the article is that *ST Sailong's wholly-owned subsidiary, Hunan Sailong Pharmaceutical (Changsha) Co., Ltd., has received the drug registration certificate for Famotidine injection from the National Medical Products Administration [1] - Famotidine injection is classified as a Class A drug in the National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalog (2024) [1] - The drug is primarily indicated for treating upper gastrointestinal bleeding caused by peptic ulcers and other non-tumor related causes of gastric and duodenal mucosal erosion and bleeding, excluding esophageal and gastric variceal bleeding [1]